Who is sponsoring NCT02128971?

NCT02128971 is sponsored by Albion.

What drugs are being tested in NCT02128971?

Interventions: Ferrochel® 90 mg, Sumalate® 90 mg, Ferrous fumarate 90 mg, Ferrous Sulfate 90 mg, Ferric Glycinate 90 mg, Placebo.

What is the status of NCT02128971?

NCT02128971 is currently UNKNOWN.

Last reviewed 2014-05-05 · How we verify

A Study to Compare the Gastrointestinal Tolerability of Ferrochel®, Sumalate®,Ferrous Fumarate, Ferrous Sulfate, Ferric Glycinate, and Placebo

NCT02128971 Phase 2 UNKNOWN

The purpose of this study is to compare the gastrointestinal (GI) tolerability of 5 different iron supplements (Ferrochel®, Sumalate®,ferrous fumarate, ferrous sulfate and ferric glycinate) at the same dose (90mg) and placebo.

Details

Lead sponsor	Albion
Phase	Phase 2
Status	UNKNOWN
Enrolment	108
Start date	2014-04
Completion	2014-08

Conditions

Anemia

Interventions

Ferrochel® 90 mg
Sumalate® 90 mg
Ferrous fumarate 90 mg
Ferrous Sulfate 90 mg
Ferric Glycinate 90 mg
Placebo

Primary outcomes

Gastrointestinal questionnaire to measure the gastrointestinal tolerability — change from baseline in Gastrointestinal questionnaire on 7 days after the last dose of 30 days investigational product consumption
The gastrointestinal tolerability of the products will be assessed by self-assessment questionnaires and self-reported diaries at baseline (screening), day 0, day 15, day 30 of investigational product consumption, and 7 days after finished the investigational product.

Countries

Indonesia